These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 2779137)

  • 1. [Ototoxicity of cisplatin in children with malignant diseases].
    Hadjilaskari P; Fengler R; Hartmann R; Henze G
    Klin Padiatr; 1989; 201(4):316-21. PubMed ID: 2779137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hearing loss in children with brain tumors treated with cisplatin and carboplatin-based high-dose chemotherapy with autologous bone marrow rescue.
    Freilich RJ; Kraus DH; Budnick AS; Bayer LA; Finlay JL
    Med Pediatr Oncol; 1996 Feb; 26(2):95-100. PubMed ID: 8531860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platinum compound-related ototoxicity in children: long-term follow-up reveals continuous worsening of hearing loss.
    Bertolini P; Lassalle M; Mercier G; Raquin MA; Izzi G; Corradini N; Hartmann O
    J Pediatr Hematol Oncol; 2004 Oct; 26(10):649-55. PubMed ID: 15454836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ototoxicity in patients receiving cisplatin: importance of dose and method of drug administration.
    Reddel RR; Kefford RF; Grant JM; Coates AS; Fox RM; Tattersall MH
    Cancer Treat Rep; 1982 Jan; 66(1):19-23. PubMed ID: 7198012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Monitoring hearing during ototoxic cisplatin therapy].
    Kluba J; Kluba U; von Specht H; Mittler U
    Padiatr Grenzgeb; 1990; 29(1):19-23. PubMed ID: 2342815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Ototoxic side effects in patients with ovarian cancer treated with cisplatin].
    Behling H; Spieske C; Krafft W
    Zentralbl Gynakol; 1988; 110(5):277-82. PubMed ID: 3376611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cisplatin ototoxicity. A clinical study].
    Schröder M; Laskawi R; Stennert E; Kühnle H; Thiele FW
    Laryngol Rhinol Otol (Stuttg); 1986 Feb; 65(2):86-9. PubMed ID: 3959692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predicting cisplatin ototoxicity in children: the influence of age and the cumulative dose.
    Li Y; Womer RB; Silber JH
    Eur J Cancer; 2004 Nov; 40(16):2445-51. PubMed ID: 15519518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hearing loss caused by high dose carboplatin therapy].
    Lautermann J; Adamczyk M; ten Cate WJ; Kloke O
    Laryngorhinootologie; 1998 Feb; 77(2):82-4. PubMed ID: 9555700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cisplatin and carboplatin-induced ototoxicity in children: clinical aspects and perspectives for prevention].
    Montaguti M; Brandolini C; Ferri GG; Hatzopoulos S; Prete A; Pession A
    Acta Otorhinolaryngol Ital; 2002 Feb; 22(1):14-8. PubMed ID: 12236007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Ototoxicity of cisplatin chemotherapy in patients with ovarian cancer].
    Beck E; Schuster M; Berg A; Jäger W; Wildt L; Lang N
    Gynakol Rundsch; 1991; 31 Suppl 2():280-5. PubMed ID: 1790954
    [No Abstract]   [Full Text] [Related]  

  • 12. The incidence of hearing impairment after successful treatment of neuroblastoma.
    Simon T; Hero B; Dupuis W; Selle B; Berthold F
    Klin Padiatr; 2002; 214(4):149-52. PubMed ID: 12165893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-dose Cisplatin with amifostine: ototoxicity and pharmacokinetics.
    Ekborn A; Hansson J; Ehrsson H; Eksborg S; Wallin I; Wagenius G; Laurell G
    Laryngoscope; 2004 Sep; 114(9):1660-7. PubMed ID: 15475801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of high-frequency audiometry increases the diagnosis of asymptomatic hearing loss in pediatric patients treated with cisplatin-based chemotherapy.
    Abujamra AL; Escosteguy JR; Dall'Igna C; Manica D; Cigana LF; Coradini P; Brunetto A; Gregianin LJ
    Pediatr Blood Cancer; 2013 Mar; 60(3):474-8. PubMed ID: 22744939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cisplatin-based chemotherapy: Add high-frequency audiometry in the regimen.
    Arora R; Thakur JS; Azad RK; Mohindroo NK; Sharma DR; Seam RK
    Indian J Cancer; 2009; 46(4):311-7. PubMed ID: 19749461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distortion product otoacoustic emissions: an objective technique for the screening of hearing loss in children treated with platin derivatives.
    Dhooge I; Dhooge C; Geukens S; De Clerck B; De Vel E; Vinck BM
    Int J Audiol; 2006 Jun; 45(6):337-43. PubMed ID: 16777780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ototoxic impact of cisplatin in pediatric oncology patients.
    Berg AL; Spitzer JB; Garvin JH
    Laryngoscope; 1999 Nov; 109(11):1806-14. PubMed ID: 10569412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ototoxicity of carboplatin: comparing animal and clinical models at the Hospital for Sick Children.
    Macdonald MR; Harrison RV; Wake M; Bliss B; Macdonald RE
    J Otolaryngol; 1994 Jun; 23(3):151-9. PubMed ID: 8064951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cisplatinum ototoxicity in children, long-term follow up.
    Al-Khatib T; Cohen N; Carret AS; Daniel S
    Int J Pediatr Otorhinolaryngol; 2010 Aug; 74(8):913-9. PubMed ID: 20846503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The ototoxicity of cisplatin: a clinical study].
    Vantrappen G; Rector E; Debruyne F
    Acta Otorhinolaryngol Belg; 1990; 44(4):415-21. PubMed ID: 2093285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.